Purified water, DPG, glycerin, niacinamide, 1,2-hexanediol, butylene glycol, polyglycerin-3, hippophae rhamnoides water, acrylates/C10-30 alkyl acrylate crosspolymer, tromethamine, erythritol, pentylene glycol, 3-O-ethyl ascorbic acid, ethylhexylglycerin, polyglyceryl-4 caprate, adenosine, glutathione, hydrogenated lecithin, disodium EDTA, madecassoside, coptis japonica root extract, decyl glucoside, caprylyl glycol, ceramide NP, ascorbic acid, bisabolol, panthenol, tocopherol, arbutin, acetyl hexapeptide-8, hexapeptide-9, nonapeptide-1, palmitoyl pentapeptide-4, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7
Accompanied by neurologic symptoms such as leg weakness, numbness, bowel or bladder dysfunction, or saddle anesthesiathese are red flags for cauda equina syndrome or severe nerve compression requiring emergency evaluation
The Anti-Obesity Drug designation reflects the original research focus of the compounds development at Monash University in Australia
The Mod GRF 1-29 article covers the without-DAC version specifically
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro
L-carnitine rarely causes allergic reactions, but they can occur
